Ikan Biotech
A company specialized in the design and development of xenograft models.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
$300k | Debt | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 700 % | 62 % | (95 %) | (69 %) | (87 %) | 96 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (4 %) | 26 % | (10 %) | (25 %) | (1275 %) | (15438 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (17 %) | 22 % | (13 %) | (205 %) | (1786 %) | (17038 %) | (14602 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Ikan Biotech is a biotechnology company specializing in the development of zebrafish in vivo models for drug discovery and development. The company serves pharmaceutical and biotechnology firms by providing innovative zebrafish tumor models, xenograft models, and toxicity assays. Operating in the human healthcare market, Ikan Biotech's business model revolves around offering specialized research services that help clients test the efficacy and safety of potential drugs. The company generates revenue through service contracts and collaborative research agreements. By leveraging its expertise in zebrafish models, Ikan Biotech aims to reduce the cost and time associated with the drug discovery phase, particularly in cancer treatment. The company holds certifications such as ISO 9001:2015 and UNE 166002:2014, underscoring its commitment to quality and innovation.
Keywords: zebrafish models, drug discovery, xenograft, tumor models, toxicity assays, cancer treatment, pharmaceutical, biotechnology, human healthcare, innovative research.